JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders.

Ram W. Sabnis, Anika R. Sabnis

ACS Med Chem Lett April 27, 2026 DOI: 10.1021/acsmedchemlett.6c00208 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract

Characteristics	Theoretical Peer reviewed
Topics	Serotonin
Key points	Proposes that novel indoline derivatives acting as 5-HT2A agonists may serve as serotonergic psychedelic agents for treating psychosis, mental illness, and CNS disorders.

Abstract

Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders.